WO2007031620B1 - Mousses dermatologiques a base de metronidazole et emulsions pour leur preparation - Google Patents

Mousses dermatologiques a base de metronidazole et emulsions pour leur preparation

Info

Publication number
WO2007031620B1
WO2007031620B1 PCT/FR2006/002037 FR2006002037W WO2007031620B1 WO 2007031620 B1 WO2007031620 B1 WO 2007031620B1 FR 2006002037 W FR2006002037 W FR 2006002037W WO 2007031620 B1 WO2007031620 B1 WO 2007031620B1
Authority
WO
WIPO (PCT)
Prior art keywords
mass
metronidazole
emulsions
preparation
production
Prior art date
Application number
PCT/FR2006/002037
Other languages
English (en)
Other versions
WO2007031620A2 (fr
WO2007031620A3 (fr
Inventor
Dov Tamarkin
Doron Friedman
Original Assignee
Galderma Sa
Dov Tamarkin
Doron Friedman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Sa, Dov Tamarkin, Doron Friedman filed Critical Galderma Sa
Priority to EP06808065A priority Critical patent/EP1928416A2/fr
Publication of WO2007031620A2 publication Critical patent/WO2007031620A2/fr
Publication of WO2007031620A3 publication Critical patent/WO2007031620A3/fr
Publication of WO2007031620B1 publication Critical patent/WO2007031620B1/fr
Priority to US12/076,115 priority patent/US20090041678A1/en
Priority to US13/154,476 priority patent/US20110237637A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des émulsions comprenant, en pourcentage en masse par rapport à la masse totale de Ia composition : (a) 70% a 81 % d'eau ; (b) 0,1% a 5% d'un agent gélifiant de la phase aqueuse de l'émulsion ; (c) 0,75% a 2% de métronidazole ; (d) 4% a 10% d'huile minérale ; (e) 0,5% a 10% d'un agent tensioactif ; (f) 0,5% a 5% d'un acide gras ; (g) 0,1% a 5% d'un agent conservateur ; et (h) 0 a 5% d'un promoteur d'absorption du métronidazole. L'invention concerne également des mousses à base de métronidazole obtenues à partir de ces émulsions, ainsi que leur utilisation dermatologique.

Claims

40REVENDICATIONS MODIFIÉES reçues par le Bureau international le 27 Mars 2007 (27.03.2007)
1. Composition à base de métronidazole choisie parmi les compositions suivantes :
Figure imgf000002_0001
41
Figure imgf000003_0001
42
Figure imgf000004_0001
Figure imgf000005_0001
Figure imgf000005_0002
2. Procédé de préparation d'une composition selon la revendication 1 , comprenant les étapes successives suivantes : - on prépare un milieu aqueux A comprenant l'eau (a), l'agent gélifiant (b), le métronidazole (c), le tensioactif (e), et, le cas échéant, le promoteur d'absorption (h) ;
- on prépare un milieu hydrophobe H comprenant l'huile minérale (d), et tout autre constituant de la phase grasse ; - on mélange les milieux A et H ainsi obtenus, et on émulsifie le système ainsi formé ;
- le conservateur (g) est ajouté en fin d'émulsification ;
- mélange de l'émulsion obtenue avec un gaz.
3. Utilisation d'une composition selon la revendication 1 , pour la préparation d'une mousse dermatologique destinée au traitement prophylactique ou thérapeutique d'une affection cutanée, par voie topique. 44
4. Utilisation selon la revendication 3, pour la préparation d'une mousse dermatologique destinée au traitement de la rosacée.
PCT/FR2006/002037 2005-09-13 2006-09-05 Mousses dermatologiques a base de metronidazole et emulsions pour leur preparation WO2007031620A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP06808065A EP1928416A2 (fr) 2005-09-13 2006-09-05 Mousses dermatologiques a base de metronidazole et emulsions pour leur preparation
US12/076,115 US20090041678A1 (en) 2005-09-13 2008-03-13 Metronidazole-based dermatological foams and emulsions for the preparation thereof
US13/154,476 US20110237637A1 (en) 2005-09-13 2011-06-07 Metronidazole-based dermatological foam and emulsions for the production thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0509342A FR2890560B1 (fr) 2005-09-13 2005-09-13 Mousses dermatologiques a base de metronidazole et emulsions pour leur preparation
FR0509342 2005-09-13

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/076,115 Continuation US20090041678A1 (en) 2005-09-13 2008-03-13 Metronidazole-based dermatological foams and emulsions for the preparation thereof

Publications (3)

Publication Number Publication Date
WO2007031620A2 WO2007031620A2 (fr) 2007-03-22
WO2007031620A3 WO2007031620A3 (fr) 2007-05-03
WO2007031620B1 true WO2007031620B1 (fr) 2007-06-21

Family

ID=36601229

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2006/002037 WO2007031620A2 (fr) 2005-09-13 2006-09-05 Mousses dermatologiques a base de metronidazole et emulsions pour leur preparation

Country Status (4)

Country Link
US (2) US20090041678A1 (fr)
EP (1) EP1928416A2 (fr)
FR (1) FR2890560B1 (fr)
WO (1) WO2007031620A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107823123A (zh) 2011-06-28 2018-03-23 化学研究有限公司 高剂量粘膜粘附甲硝唑水基凝胶制剂及其治疗细菌性阴道病的用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837378A (en) * 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
US5536743A (en) * 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions
US5300491A (en) * 1991-10-31 1994-04-05 Apothekernes Laboratorium A.S. Treatment of protozoal infection
US6468989B1 (en) * 2000-07-13 2002-10-22 Dow Pharmaceutical Sciences Gel compositions containing metronidazole
CA2502986C (fr) * 2002-10-25 2011-08-23 Foamix Ltd. Mousse cosmetique et pharmaceutique
JP2007503428A (ja) * 2003-08-25 2007-02-22 フォーミックス エルティーディー． 浸透性医薬発泡剤
US20050255048A1 (en) * 2004-05-15 2005-11-17 Collegium Pharmaceutical, Inc. Sprayable formulations for the treatment of acute inflammatory skin conditions
US20060024243A1 (en) * 2004-08-02 2006-02-02 Agis Industries (1983) Ltd. Foamable compositions containing nitro-imidazoles, processes for preparing same and methods of treatment utilizing same

Also Published As

Publication number Publication date
US20090041678A1 (en) 2009-02-12
FR2890560A1 (fr) 2007-03-16
EP1928416A2 (fr) 2008-06-11
WO2007031620A2 (fr) 2007-03-22
FR2890560B1 (fr) 2011-06-24
US20110237637A1 (en) 2011-09-29
WO2007031620A3 (fr) 2007-05-03

Similar Documents

Publication Publication Date Title
WO2007031621B1 (fr) Mousses dermatologiques a base de metronidazole et emulsions pour leur preparation
JP2000351726A (ja) エアゾール製剤
ZA200510388B (en) Foamable pharmaceutical compositions and methods for treating a disorder
WO2004039749A1 (fr) Procede de fabrication d'une plaque de platre legere
JP2018510181A (ja) ラメラ液晶構造を持つ多重エマルジョン剤形の化粧料組成物
WO2007117720A3 (fr) Agents hydrophobes formant une dispersion stable dans des emulsions huile dans eau
WO2002078650A1 (fr) Preparation d'emulsion cosmetique et agent pour usage externe
JP4979379B2 (ja) 二液型発泡体、その安定な分散体、および対応する製造プロセス
WO2007031620B1 (fr) Mousses dermatologiques a base de metronidazole et emulsions pour leur preparation
JPH01156906A (ja) スキンコンデイショニングエアゾールフオーム組成物
JP2010018490A (ja) セメント構造物用被覆養生剤
US9408786B2 (en) Method for the treatment of skin
CA2507006A1 (fr) Procede de fabrication de produits de soin personnel au moyen d'une phase d'eau concentree
CA2798099A1 (fr) Procede de fabrication d'une composition de rasage en aerosol comprenant un agent hydrophobe formant au moins une microgouttelette
ATE395903T1 (de) Schäumende o/w-emulsion und ihre verwendung in der kosmetik
PL1622986T3 (pl) Alkidowe emulsje żywiczne dla powłok lakierniczych
WO2003082220A3 (fr) Procede pour la production d'emulsions
PT94911A (pt) Processo para a preparacao de formulacoes famaceuticamente compreendendo pelo menos propileno glicol decilmetilsulfoxido e penciclovir
JP5154780B2 (ja) 一酸化窒素産生促進剤及びその利用
US2086479A (en) Stable emulsion and method of producing the same
CN107137352B (zh) 一种新型泡沫剂
KR20180098300A (ko) 할로베타솔 발포체 조성물 및 이의 사용 방법
WO2011108538A1 (fr) Tensio-actif pour stabiliser une microémulsion eau/dioxyde de carbone supercritique
JP3072566B2 (ja) 皮膚外用剤
KR101461666B1 (ko) 발레르산 아세트산 프레드니졸론을 함유하는 ｏ/ｗ 형 유화제제

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006808065

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

WWP Wipo information: published in national office

Ref document number: 2006808065

Country of ref document: EP